Viewing Study NCT00624832


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-01 @ 6:12 PM
Study NCT ID: NCT00624832
Status: COMPLETED
Last Update Posted: 2011-04-19
First Post: 2008-02-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels
Sponsor: Novartis
Organization: